Table 1:
MN prevalence, positive study and lung cancer rate in the NLST
| Micronodule Identified on At Least One CT Screen | No Micronodules Identified | Total | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At Least One Positive CT Screening Exam | Never Positive | Total | At Least One Positive CT Screening Exam | Never Positive | Total | At Least One Positive CT Screening Exam | Never Positive | Total | ||||||||||
| N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
| Lung Cancer | 319 | 5.74 | 90 | 1.56 | 409 | 3.61 | 547 | 11.89 | 133 | 1.23 | 680 | 4.42 | 866 | 8.52 | 223 | 1.35 | 1089 | 4.08 |
| No Lung Cancer | 5241 | 94.26 | 5676 | 98.44 | 10917 | 96.39 | 4053 | 88.11 | 10663 | 98.77 | 14716 | 95.58 | 9294 | 91.48 | 16339 | 98.65 | 25633 | 95.92 |
| Total CT Randomized Participants | 5560 | 100.00 | 5766 | 100.00 | 11326 | 100.00 | 4600 | 100.00 | 10796 | 100.00 | 15396 | 100.00 | 10160 | 100.00 | 16562 | 100.00 | 26722 | 100.00 |